Only Tegaderm™ CHG Dressings combine the most critical elements of I.V. site care into a single product to help you meet your goals for patient safety, clinican confidence, and cost of care. Download product brochure.
Antimicrobial Protection: Integrated CHG gel pad provides immediate and continuous protection.
Securement: Reinforced border and notch provides catheter securement.
Site Visibility: Transparent film and gel pad allows continuous site observation.
Breathability: Promotes moisture evaporation and enhances securement.
3M™ Tegaderm™ CHG Dressings are proven to be as effective as, or better than, BIOPATCH® Protective Disk plus adhesive cover dressing at reducing skin flora and preventing regrowth.1 Tegaderm™ CHG Dressings are proven to maintain significantly lower counts than BIOPATCH® after seven days on healthy adult subjects.2
Simplifies I.V. Site Care
Tegaderm™ CHG Dressings are proven to significantly reduce the number of dressing changes and restarts which may reduce nursing time, materials cost, and the opportunity for exposure.3 The intuitive design lets you "skip the disk." The CHG gel pad is integrated into the film so it can't be dropped, forgotten or applied incorrectly--ensuring efficiency and consistency of care.5
You get CHG protection plus an I.V. securement cover dressing in a single dressing, simplifying product selection, application and inventory control. Tegaderm™ CHG Dressings accommodate a majority of catheters and can be safely worn for up to seven days—or for the length of your facility protocol.
Increases Consistent and Correct Application4
In clinical practice, the BIOPATCH® disk is often laid on top of the catheter at the insertion site, greatly diminishing its efficacy.1
Preferred by Clinicians
As part of a clinical evaluation, professional I.V. nurses were trained in proper application and removal techniques for Tegaderm™ CHG Dressings and CHG sponge disks plus cover dressing. Immediately after training, they applied the dressings and rated Tegaderm™ CHG Dressings significantly better on all criteria:
- Overall performance
- Ease of correct application5
- Ability to see the I.V. site
- Ease of training another clinician4
- Ability of the gel pad to conform around the catheter
- Ability to absorb fluid
Supports Compliance with Industry Guidelines
Tegaderm™ CHG Dressings support the goals of professional standards, guidelines and facility protocols for improving patient outcomes.
- The CDC/HICPAC Guidelines for the Prevention of Intravascular Catheter-Related Infections recommends using transparent film dressings.
- The Infusion Nurses Standards of Practice recommends that a sterile dressing be applied and maintained to provide protection of the I.V. site.
- Tegaderm™ CHG Dressings meet the CDC Category II recommendation for a catheter securement device and the INS Standard 36, Practice A, guideline recommending use of a catheter stabilization device.
1. Maki DG. A Novel Integrated Chlorhexidine-Impregnated Transparent Dressing for Prevention of Vascular Catheter-related Bloodstream Infection: A Prospective Comparitive Study in Healthy Volunteers. SHEA, April 2008.
2. Bashir MH, et al. Suppression of regrowth of normal skin flora under chlorhexidine gluconate dressings applied to chlorhexidine gluconate-prepped skin. American Journal of Infection Control (AJIC), 2012; 40(4):344-8.
3. Timsit JF, et al. Randomized Controlled Trial of Chlorhexidine Dressing and Highly Adhesive Dressing for Preventing Catheter-Related Infections in Critically Ill Adults. American Journal of Respiratory and Critical Care Medicine, 2012; Vol. 186 No. 12.
4. Eyberg C. A Controlled Randomized Prospecitve Comparative Study to Evaluate the Ease of Use of a Transparent Chlorhexidine Impregnated Gel Dressing Versus a Chlorhexidine Disk in Health Volunteers. Journal of the Association for Vascular Access (JAVA), Fall 2008 Vol. 13 No. 3.
5.Kohan, Cynthia MT, MS, CIC; Boyce, John MD. Poster "A Different Experience with Two Chlorhexidine Gluconate Dressings for Use on Central Venous Devices." APIC, Ft. Lauderdale FL, June 2013.
Immediate and Continuous Antimicrobial Protection
The soft gel pad diffuses CHG around the insertion site, including under the catheter hub.1,2 The CHG is immediately active and does not require moisture to activate,2 providing continuous protection for up to seven days, even on dry skin.2 The CHG gel pad can absorb perspiration, exudate and blood without compromising antimicrobial activity or site visibility.2,3
3M™ Tegaderm™ CHG Dressings are proven to be as effective as, or better than, BIOPATCH® Protective Disk plus adhesive cover dressing at reducing skin flora and preventing regrowth.4 Tegaderm™ CHG Dressings are proven to maintain significantly lower counts than BIOPATCH® after seven days on healthy adult subjects.5
Reduces Skin Flora4
In vivo kill time of normal flora on unprepped skin with the two CHG dressings on healthy adult volunteers (P=0.008).
Suppression of regrowth on prepped subclavian sites with the two CHG dressings on healthy adult volunteers (P=0.0003).
Provides Comprehensive Antimicrobial Protection
3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressings have demonstrated in vitro antimicrobial efficacy against a broad range of organisms known to cause CRBSIs.*6
Maintains Low Skin Organism Counts5
Pairwise testing done against Tegaderm™ CHG Dressing using a paired t-test with Holm stepwise adjustment for multiple comparisons.
Common Pathogens Causing CRBSIs7
The transparent film provides a waterproof, sterile barrier to contaminants including liquids, viruses, and a broad range of bacteria and yeast commonly found in CRBSIs.**
* 3M™ Tegaderm™ CHG Dressings have not been studied in a randomized clinical study as to their effectiveness in reducing CRBSIs.
** In vitro testing shows that the transparent film of 3M™ Tegaderm™ CHG Dressings provides a viral barrier from viruses 27 nm in diameter or larger while the dressing remains intact without leakage.
1. Schwab D. Antimicrobial Activity of a CHG-Impregnated Gel Pad for IV Site Protection. Infusion Nurses Society (INS), May 2008.
2. Karpanen TJ, et al. Antimicrobial Activity of a Chlorhexidine Intravascular Catheter Site Gel Dressing. Journal of Antimicrobial Chemotherapy, May 2011; 66: 1777-1784.
3. Olson C. Clinical Performance of a New Transparent Chlorhexidine Gluconate Central Venous Catheter Dressing. Journal of the Association for Vascular Access (JAVA), March 2008; Vol. 13 No. 1 13-19.
4. Maki DG. A Novel Integrated Chlorhexidine-Impregnated Transparent Dressing for Prevention of Vascular Catheter-related Bloodstream Infection: A Prospective Comparitive Study in Healthy Volunteers. SHEA, April 2008.
5. Bashir MH, et al. Suppression of Regrowth of Normal Skin Flora Under Chlorhexidine Gluconate Dressings Applied to Chlorhexidine Gluconate-prepped Skin. American Journal of Infection Control (AJIC), 40(4):344-8.
6. Hensler J. Growth inhibition of microorganisms involved in CA-infections by an antimicrobial transparent IV dressing containing CHG. European Society of Clinical Microbiology and Infectious Diseases, May 2009.
7. Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-related Infections. Healthcare Infection Control Practices Advisory Committee (HICPAC); (Appendix 1). Clin Infect Dis. 2011;52(9):e162.
Delivers Exceptional Securement
The reinforced border and deep notch work together to enlist the entire dressing in securement. The gel pad clings to the catheter providing complete coverage and added stability. The highly breathable pattern-coated adhesive promotes evaporation of moisture for enhanced adhesion.
Requires More Force to Dislodge*
Tegaderm™ CHG Dressings (1657 and 1658) with securement tape strips require significantly more force to dislodge a PICC.
* 3M data on file.
Enables Continuous Site Visibility
The gel pad and film remain transparent, so you always have full visibility of the insertion site to monitor for early signs of infection. The CDC recommends the use of transparent film dressings for I.V. site care because they: "…reliably secure the device, permit continuous visual inspection of the catheter site...and require less frequent changes than do standard gauze and tape dressings; the use of these dressings saves personnel time."1
1. Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-related Infections. Healthcare Infection Control Practices Advisory Committee (HICPAC); (Appendix 1). Clin Infect Dis. 2011;52(9):e162.
One Product for All Your I.V. Site Needs
|PRODUCT CODE||OVERALL DRESSING SIZE||GEL PAD SIZE||SUGGESTED DEVICES||DRESSINGS/ BOX||BOXES/ CASE||HCPCS Code|
||3 ½ in. x 4 ½ in.
8,5 cm x 11,5 cm
|1 ½ in. x 1 3/8 in.
3 cm x 4 cm
|All CVCs, Arterial, Dialysis, Midline, Other percutaneous devices||25||4||A6257|
||4 in. x 4 ¾ in.
10 cm x 12 cm
|1 ½ in. x 1 3/8 in.
3 cm x 4 cm
|Universal, Other percutaneous devices||25||4||A6257|
||4 in. x 6 1/8 in.
10 cm x 15,5 cm
|1 ½ in. x 2 4/5 in.
3 cm x 7 cm
|All CVCs, PICC||25||4||A6258|
||2 ¾ in. x 3 3/8 in.
7 cm x 8,5 cm
|4/5 in. x 4/5 in.
2 cm x 2 cm
|All CVCs, Arterial, Midline, Other percutaneous devices||25||4||A6257|
*3M™ Tegaderm™ CHG Dressings are not indicated to replace sutures for short-term central venous catheters, e.g. subclavian, jugular, femoral.
Application & Removal Videos
- Short peripheral and midline venous catheters
- Central venous catheters (CVC)
- Internal jugular (IJ) vein
- Femoral vein
- Subclavian vein
- Peripherally inserted central catheters (PICC)
- Tunneled CVCs
- Implanted infusion devices (ports)
- Arterial catheters
- Dialysis catheters
- Any percutaneous device
Prepare the site according to your facility's protocol.
Clipping hair at the site may improve dressing adhesion. Shaving is not recommended.
3M™ Cavilon™ No Sting Barrier Film may be used with Tegaderm™ CHG Dressings. Apply Cavilon No Sting Barrier FIlm evenly to the skin. Avoid the area immediately surrounding the insertion site to allow direct contact between the CHG gel pad and the skin.
Allow all preps and protectants to dry completely before applying Tegaderm CHG Dressings to ensure good adhesion and prevent skin irritation.
Choose a dressing large enough to provide at least a one-inch margin of adherence on dry, healthy skin around the catheter site.
Follow universal precautions as indicated by established protocol for infection prevention.
If infection is suspected, remove dressing, inspect the catheter site directly, and determine appropriate medical intervention.
Tegaderm™ CHG Dressings should be changed:
- If there is visible drainage outside the gel pad.
- If the dressing becomes loose, soiled or compromised in any way.
- If the site is obscured or no longer visible.
- If the dressing appears to be saturated or overly swollen.
- Every seven days or according to established facility protocol.
NOTE: Tegaderm™ CHG Dressings are not designed to absorb large quantities of blood or drainage.